Details for Patent: 11,141,378
✉ Email this page to a colleague
Which drugs does patent 11,141,378 protect, and when does it expire?
Patent 11,141,378 protects ONPATTRO and is included in one NDA.
This patent has twenty-one patent family members in thirteen countries.
Summary for Patent: 11,141,378
| Title: | Lipid formulations for nucleic acid delivery |
| Abstract: | The present invention provides novel, stable lipid particles comprising one or more active agents or therapeutic agents, methods of making the lipid particles, and methods of delivering and/or administering the lipid particles. More particularly, the present invention provides stable nucleic acid-lipid particles (SNALP) comprising a nucleic acid (such as one or more interfering RNA), methods of making the SNALP, and methods of delivering and/or administering the SNALP. |
| Inventor(s): | Edward Yaworski, Kieu Lam, Lloyd Jeffs, Lorne Palmer, Ian Maclachlan |
| Assignee: | Arbutus Biopharma Corp |
| Application Number: | US17/227,802 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 11,141,378 |
|
Patent Claim Types: see list of patent claims | Composition; |
Drugs Protected by US Patent 11,141,378
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Alnylam Pharms Inc | ONPATTRO | patisiran sodium | SOLUTION;INTRAVENOUS | 210922-001 | Aug 10, 2018 | RX | Yes | Yes | 11,141,378 | ⤷ Start Trial | Y | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 11,141,378
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2008342535 | ⤷ Start Trial | |||
| Australia | 2009238175 | ⤷ Start Trial | |||
| Canada | 2710713 | ⤷ Start Trial | |||
| Canada | 2721333 | ⤷ Start Trial | |||
| China | 102119217 | ⤷ Start Trial | |||
| Denmark | 2279254 | ⤷ Start Trial | |||
| European Patent Office | 2238251 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
